Arca
Skip to content
Tools
Tools

DNA

Nucleic acid in Trichomonas that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved1

  • Tinidazole

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        TinidazoleBoxed warningApprovedMission PharmaSmall moleculeDisrupting agentDNA disrupting agent8

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Probiotics Versus Antibiotics as an Adjuvant to Non-surgical Periodontal Treatment Among Smokers With Stage II, Grade B PeriodontitisTinidazoleNot applicableRecruitingOctober 6 UniversityNov 6, 2026
        Bacillus Probiotics With Bismuth Quadruple Therapy for Helicobacter Pylori InfectionTinidazoleNot applicableNot yet recruitingAnabio R&DSep 18, 2026
        Metronidazole- Versus Tinidazole-Based Bismuth Quadruple Therapy for Helicobacter Pylori EradicationTinidazoleNot applicableNot yet recruitingUniversity of Medicine and Pharmacy at Ho Chi Minh CityAug 5, 2026
        Vonoprazan High-Dose Dual VS Levofloxacin ConcomitantTinidazolePhase 4Not yet recruitingDamascus HospitalJun 3, 2026
        Levofloxacin-Based Sequential Therapy Versus Bismuth Quadruple Therapy for Helicobacter Pylori EradicationTinidazoleNot applicableNot yet recruitingUniversity of Health Sciences LahoreMay 8, 2026
        "Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"TinidazolePhase 2RecruitingUniversity of WashingtonJul 28, 2025
        Clinical Study on the Impact of Eradication of Oral Porphyromonas Gingivalis on the Prognosis of Early Esophageal Cancer After ESD SurgeryTinidazoleNot applicableActive, not recruitingThe First Affiliated Hospital of Henan University of Science and TechnologyDec 9, 2024
        Clinical Study on the Effect of Removal of Porphyromonas Gingivalis on Prognosis of Esophageal Cancer After Radical SurgeryTinidazolePhase 3Not yet recruitingThe First Affiliated Hospital of Henan University of Science and TechnologyMay 17, 2024

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2366045, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.